Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
NCT02753894
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Interventions
DRUG:
ASP1585
Sponsor
Astellas Pharma Inc